Market Scenario
Antihistamines are drugs mainly used for treating allergies. They are also used to treat motion sickness, insomnia and anxiety. They work by acting against a chemical called histamine which leads to many allergic symptoms. Antihistamines may cause side effects such as dizziness, dry mouth, nervousness, irritability, blurry vision and decreased appetite.
The global antihistamine drugs market is expected to grow at a CAGR of 9.8% during the forecast period and is estimated to reach USD 280 million by 2023.
Get Sample Copy @ https://www.marketresearchfuture.com/sample_request/4266
Segments
The global antihistamine drugs market is segmented on the basis of types which includes sedating and non-sedating antihistamines. Sedating antihistamines are further sub-segmented into brompheniramine, chlorpheniramine, diphenhydramine, doxylamine, carbinoxamine and others. Non-sedating antihistamines are further sub-segmented into fexofenadine, loratadine, loratadine odt, and others.
On the basis of route of administration, the market is segmented into oral route, parenteral route and rectal route. Parenteral route segmented is further sub-segmented into intramuscular, subcutaneous and intravenous route.
On the basis of indication, the market is segmented into allergy, urticaria, dermatitis, and others. And on the basis of end users, the market is segmented into hospitals, clinics, pharmaceutical companies and others.
- Key Players in the Global Antihistamine drugs Market
- Johnson & Johnson Consumer Inc. (U.S.)
- Sanofi (France)
- Bayer AG (Germany)
- Pfizer (U.S.)
- CVS pharmacy (U.S.)
- Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc. (U.S.)
- Prestige Brands Holdings, Inc.
Regional Analysis of the Global Antihistamine drugs Market
The American region accounts for the largest share of the global market due to rising prevalence of allergy rhinitis and rising demand for diagnosis and treatment of allergic disease. According to the American College of Allergy Asthma and Immunology, allergic asthma, food allergy, and eczema are the most common types of allergies found in the U.S.
Europe is the second largest market that holds a noticeable share of the global antihistamine drugs market. According to the European Academy of Allergy and Clinical Immunology (EAACI), more than 50% of all Europeans will suffer from allergy in coming years.
In Asia Pacific, increase in the demand for drugs for the treatment of allergies and skin diseases drive the market growth. There has been a rise in the number of dermatology clinics across Asia Pacific from past few years. High rates of allergic rhinitis and increasing awareness regarding treatments available for allergy is poised to drive the growth of this market in Asia Pacific.
The Middle East & Africa, the market shows steady but positive growth due to the rising prevalence of nasal allergies.
Browse Complete 206 Pages Premium Research Report Enabled with Respective Tables and Figures @ https://www.marketresearchfuture.com/reports/antihistamine-drugs-market-4266
